Comparative study of the clinico-trichoscopic response to treatment of hirsutism with long pulsed (1064 nm) Nd:YAG laser in idiopathic hirsutism and polycystic ovarian syndrome patients.


Journal

Lasers in medical science
ISSN: 1435-604X
Titre abrégé: Lasers Med Sci
Pays: England
ID NLM: 8611515

Informations de publication

Date de publication:
Feb 2022
Historique:
received: 18 01 2021
accepted: 19 03 2021
pubmed: 27 3 2021
medline: 3 2 2022
entrez: 26 3 2021
Statut: ppublish

Résumé

Treatment of hirsutism is usually resistant, and from medical management to laser hair reduction, the treatment of hirsutism and its assessment are the most challenging. The aim of the study was to compare the response to treatment by laser hair reduction with long pulsed (1064 nm) Nd:YAG laser in patients of idiopathic hirsutism and polycystic ovarian syndrome (PCOS) by clinical and trichoscopic assessment. A hospital-based comparative, observational prospective study was carried out on female patients with hirsutism over a period of 18 months with two groups of participants: fifty women with idiopathic hirsutism (group A) and fifty with PCOS (group B). Laser hair reduction was done with long pulsed (1064 nm) Nd:YAG laser in both groups up to six sessions, 4 weeks apart and followed for 3 months post last laser session. After the sixth session of laser hair reduction, excellent response (> 75% reduction) from baseline was seen in 70% of patients in group A and in 54% of patients in group B. After 3 months of follow-up of the last laser session, it was found that the results persisted in patients with idiopathic cause than in those due to PCOS, seen both clinically and trichoscopically with decrease in hair shaft thickness, hair shaft colour, terminal vs. vellus hair ratio and hair density per cm

Identifiants

pubmed: 33768489
doi: 10.1007/s10103-021-03295-0
pii: 10.1007/s10103-021-03295-0
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

545-553

Informations de copyright

© 2021. The Author(s), under exclusive licence to Springer-Verlag London Ltd., part of Springer Nature.

Références

Azziz R (2003) The evaluation and management of hirsutism. Obstet Gynecol 101:995–1007
pubmed: 12738163
Azziz R (2005) Diagnostic criteria for polycystic ovary syndrome: a reappraisal. Fertil Steril 83:1343–1346
doi: 10.1016/j.fertnstert.2005.01.085
González F (2012) Inflammation in polycystic ovary syndrome: underpinning of insulin resistance and ovarian dysfunction. Steroids 77:300–305
doi: 10.1016/j.steroids.2011.12.003
The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 19:41–47
doi: 10.1093/humrep/deh098
Kirschner MA, Zucker R, Jespersen D (1976) Idiopathic hirsutism—an ovarian abnormality. N Engl J Med 294:637–641
doi: 10.1056/NEJM197603182941204
Pugeat M, Forest MG, Nisula BC, Corniau J, De Peretti E, Tourniaire J (1982) Evidence of excessive androgen secretion by both the ovary and the adrenal in patients with idiopathic hirsutism. Obstet Gynecol 59:46–51
pubmed: 6804896
Kirschner MA, Samojlik E, Szmal E (1987) Clinical usefulness of plasma androstanediolglucuronide measurements in women with idiopathic hirsutism. J Clin Endocrinol Metab 65:597–601
doi: 10.1210/jcem-65-4-597
Azziz R, Waggoner WT, Ochoa T, Knochenhauer ES, Boots LR (1998) Idiopathic hirsutism: an uncommon cause of hirsutism in Alabama. Fertil Steril 70:274–278
doi: 10.1016/S0015-0282(98)00141-1
Mcknight E (1964) The prevalence of “hirsutism” in young women. Lancet. 1:410–413
doi: 10.1016/S0140-6736(64)92789-8
Altshuler GB, Anderson RR, Manstein D, Zenzie HH, Smirnov MZ (2001) Extended theory of selective photothermolysis. Lasers Surg Med 29:416–432
doi: 10.1002/lsm.1136
Bhat YJ, Bashir S, Nabi N, Hassan I (2020) Laser treatment in hirsutism: An Update. Dermatol Pract Concept 10:e2020048
doi: 10.5826/dpc.1002a48
Puri N (2012) A study of clinical and hormonal profile of the patients with hirsutism. Our Dermatol Online 3:88–91
doi: 10.7241/ourd.20122.18
Miteva M, Tosti A (2012) Hair and scalp dermatoscopy. J Am Acad Dermatol 67:1040–1048
doi: 10.1016/j.jaad.2012.02.013
Inui S (2012) Trichoscopy: a new frontier for the diagnosis of hair. Exp Rev Dermatol 7:429–437
doi: 10.1586/edm.12.40
Mubki T, Rudnicka L, Olszewska M, Shapiro J (2014) Evaluation and diagnosis of the hair loss patient: part II. Trichoscopic and laboratory evaluations. J Am Acad Dermatol 71(431):e1–e11
Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W et al (2009) Task force on the phenotype of the polycystic ovary syndrome of the androgen excess and PCOS society. The androgen excess and PCOS society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril 91:456–488
doi: 10.1016/j.fertnstert.2008.06.035
Hatch R, Rosenfield RL, Kim MH, Tredway D (1981) Hirsutism: implications, etiology, and management. Am J Obstet Gynecol 140:815–830
doi: 10.1016/0002-9378(81)90746-8
Chhabra S, Gautam RK (2012) Hirsutism: A clinico-investigative study. Int J Trichol 4:246–250
doi: 10.4103/0974-7753.111204
Sharma NL, Mahajan VK, Jindal R, Gupta M, Lath A (2008) Hirsutism: clinico-investigative profile of 50 Indian patients. Indian J Dermatol 53:111–114
doi: 10.4103/0019-5154.42387
Majumdar A, Singh TA (2009) Comparison of clinical features and health manifestations in lean versus obese Indian women with polycystic ovarian syndrome. J Hum Reprod Sci 2:12–17
doi: 10.4103/0974-1208.51336
Wijeyaratne CN, Balen AH, Barth JH, Belchetz PE (2002) Clinical manifestations and insulin resistance (IR) in polycystic ovary syndrome (PCOS) among South Asians and Caucasians: is there a difference? Clin Endocrinol 57:343–350
doi: 10.1046/j.1365-2265.2002.01603.x
Tayob Y, Robinson G, Adams J, Nyle M, Whitelaw N, Shaw R et al (1990) Ultrasound appearance of the ovaries during the pill free interval. Br J Fam Plan 16:94–96
Ramanand SJ, Ghongane BB, Ramanand JB, Patwardhan MH, Ghanghas RR, Jain SS (2013) Clinical characteristics of polycystic ovary syndrome in Indian women. Indian J Endocrinol Metab 17:138–145
doi: 10.4103/2230-8210.107858
DeplewsCodner E, Iñíguez G, Villarroel C, Lopez P, Soto N, Sir Petermann T, Cassorla F, Rey RA (2007) Hormonal profile in women with polycystic ovarian syndrome with or without type 1 diabetes mellitus. J Clin Endocrinol Metab 92:4742–4746
doi: 10.1210/jc.2007-1252
Dramusic V, Rajan U, Chan P, Ratnam SS, Wong YC (1997) Adolescent polycystic ovary syndrome. Ann N Y Acad Sci 816:194–208
doi: 10.1111/j.1749-6632.1997.tb52143.x
Bunker CB, Newton JA, Kilborn J, Patel A, Conway GS, Jacobs HS et al (1989) Most women with acne have polycystic ovaries. Br J Dermatol 121:675–680
doi: 10.1111/j.1365-2133.1989.tb08208.x
Jansy R, Manickam N, Kandasamy M, Gopalan K, Revathi D (2018) Efficacy of long pulsed Nd:YAG laser in the treatment of hirsutism IP Indian. J Clin Exp Dermatol 4:85–89
Mittal R, Sriram S, Sandhu K (2008) Evaluation of long pulsed 1064 nm Nd:YAG laser-assisted hair removal vs. multiple treatment sessions and different hair types in Indian patients. J Cutan Aesthet Surg 1:75
doi: 10.4103/0974-2077.44163
Karn D, Krishna C, Timalsina M, Gyawali P (2014) Hormonal profile and efficacy of long pulse Nd-YAG laser in treatment of hirsutism. J Nepal Health Res Counc 12:59–62
pubmed: 25574987
Goldberg DJ, Silapunt S (2001) Hair Removal using a long pulsed Nd:YAG laser: comparison at fluences of 50, 80, and 100 J/cm2. Dermatol Surg 27:434–436
pubmed: 11359488
Alajlan A, Shapiro J, Rivers JK, MacDonald N, Wiggin J, Lui H (2005) Paradoxical hypertrichosis after laser epilation. J Am Acad Dermatol 53:85–88
doi: 10.1016/j.jaad.2004.06.054
Mohamed EE, Ahmed AM, Tawfik KM, Ibrahim SM (2016) Trichoscopic changes in hair during treatment of hirsutism with 1064-nm neodymium:yttrium-aluminum-garnet laser. J Cosmet Dermatol 15:31–35
doi: 10.1111/jocd.12164

Auteurs

Nahida Nabi (N)

Postgraduate Department of Dermatology, Venereology and Leprosy, Government Medical College, Srinagar, University of Kashmir, Srinagar, Jammu and Kashmir, India.

Yasmeen Jabeen Bhat (YJ)

Postgraduate Department of Dermatology, Venereology and Leprosy, Government Medical College, Srinagar, University of Kashmir, Srinagar, Jammu and Kashmir, India. yasmeenasif76@gmail.com.

Uzair Khursheed Dar (UK)

Postgraduate Department of Dermatology, Venereology and Leprosy, Government Medical College, Srinagar, University of Kashmir, Srinagar, Jammu and Kashmir, India.

Aijaz Hakeem (A)

Postgraduate Department of Radiology, Government Medical College, Srinagar, University of Kashmir, Srinagar, Jammu and Kashmir, India.

Shahnaz A Mir (SA)

Department of Endocrinology, Government Medical College, Srinagar, University of Kashmir, Srinagar, Jammu and Kashmir, India.

Iffat Hassan Shah (IH)

Postgraduate Department of Dermatology, Venereology and Leprosy, Government Medical College, Srinagar, University of Kashmir, Srinagar, Jammu and Kashmir, India.

Mohd Rafiq Tilwani (MR)

Postgraduate Department of Dermatology, Venereology and Leprosy, SKIMS Medical College, Srinagar, Jammu and Kashmir, India.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH